Alamar Biosciences' CEO is Yuling Luo, appointed in May 2018, has a tenure of 8.17 years. total yearly compensation is $3.28M, comprised of 14.8% salary and 85.2% bonuses, including company stock and options. directly owns 4.46% of the company’s shares, worth $80.14M. The average tenure of the management team and the board of directors is 2.9 years and 6.2 years respectively.
How has Yuling Luo's remuneration changed compared to Alamar Biosciences's earnings?
Date
Total Compensation
Salary
Company Earnings
Mar 31 2026
n/a
n/a
-US$43m
Dec 31 2025
US$3m
US$483k
-US$30m
Compensation vs Market: Yuling's total compensation ($USD3.28M) is below average for companies of similar size in the US market ($USD5.16M).
Compensation vs Earnings: Insufficient data to compare Yuling's compensation with company performance.
CEO
Yuling Luo (62 yo)
8.2yrs
Tenure
US$3,275,989
Compensation
Dr. Yuling Luo, Ph D., is a Venture Partner at Iif Management Company, LLC. He is Co-Founder and Director of Attovia Therapeutics, Inc. From August 2016 to February 2018, Dr. Luo served as President, Advan...
Leadership Team
Name
Position
Tenure
Compensation
Ownership
Yuling Luo
Co-Founder
8.2yrs
US$3.28m
4.46% $ 80.1m
Shiping Chen
Co-Founder
7.9yrs
US$1.58m
1.04% $ 18.8m
Justin McAnear
Chief Financial Officer
less than a year
US$1.94m
no data
Timothy White
President
less than a year
no data
0.66% $ 11.8m
Yiyuan Yin
Founder
no data
no data
no data
Xiao-Jun Ma
Chief Technology Officer
5.1yrs
no data
no data
Stephen Williams
Chief Scientific Officer
less than a year
no data
no data
Alex Forrest-Hay
Senior Vice President of Sales
no data
no data
no data
Anna Berdine
Senior Vice President of Marketing
no data
no data
no data
Micah Litow
Senior VP of AI & Strategic Initiatives
no data
no data
no data
2.9yrs
Average Tenure
62yo
Average Age
Experienced Management: ALMR's management team is considered experienced (2.9 years average tenure).
Board Members
Name
Position
Tenure
Compensation
Ownership
Yuling Luo
Co-Founder
8.2yrs
US$3.28m
4.46% $ 80.1m
Shiping Chen
Co-Founder
6.2yrs
US$1.58m
1.04% $ 18.8m
Nicholas Naclerio
Independent Director
6.2yrs
no data
no data
Franklin Witney
Lead Independent Director
less than a year
no data
0% $ 0
Rebecca Chambers
Independent Director
less than a year
no data
no data
6.2yrs
Average Tenure
63yo
Average Age
Experienced Board: ALMR's board of directors are considered experienced (6.2 years average tenure).
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/20 12:02
End of Day Share Price
2026/07/20 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Alamar Biosciences, Inc. is covered by 5 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.